3

MAIN DOCUMENT DESCRIPTION

Company: Protalix BioTherapeutics, Inc.
Filed: December 23, 2009
Period of Report: December 17, 2009
Accession Number: 0001209191-09-058622

View Document ↗ View on SEC.gov ↗